Han B, Lin S, Ye W, Chen A, Liu Y, Sun D
Int J Mol Sci. 2025; 26(5).
PMID: 40076877
PMC: 11899919.
DOI: 10.3390/ijms26052255.
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Plessis-Belair J, Russo T, Riessland M, Sher R
bioRxiv. 2025; .
PMID: 39975276
PMC: 11838365.
DOI: 10.1101/2025.01.28.635269.
Warren B, Tan K, Rajan D, Witheford M, Crawford S, Jaberi A
JVS Vasc Sci. 2025; 6:100277.
PMID: 39906027
PMC: 11791325.
DOI: 10.1016/j.jvssci.2024.100277.
Alavimanesh S, Nayerain Jazi N, Choubani M, Saeidi F, Afkhami H, Yarahmadi A
Clin Exp Med. 2025; 25(1):44.
PMID: 39849183
PMC: 11759293.
DOI: 10.1007/s10238-025-01564-8.
Prognostic significance of p27 in colorectal cancer: a meta-analysis and bioinformatics analysis.
Zou J, Wang D, Yin G, Lu K, Chang K, Li H
Front Oncol. 2025; 14:1495476.
PMID: 39845325
PMC: 11751620.
DOI: 10.3389/fonc.2024.1495476.
Methyltransferase-like 7B participates in bladder cancer via ACSL3 mA modification in a ferroptosis manner.
He J, Dong C, Song X, Qiu Z, Zhang H, Jiang Y
Biol Direct. 2025; 20(1):9.
PMID: 39833962
PMC: 11744867.
DOI: 10.1186/s13062-025-00597-z.
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer.
Klocker E, Egle D, Bartsch R, Rinnerthaler G, Gnant M
Drugs. 2025; 85(2):149-169.
PMID: 39820840
PMC: 11802638.
DOI: 10.1007/s40265-024-02144-y.
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.
Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
TH301 Emerges as a Novel Anti-Oncogenic Agent for Human Pancreatic Cancer Cells: The Dispensable Roles of p53, CRY2 and BMAL1 in TH301-Induced /p21 Upregulation.
Farmakis D, Stravopodis D, Prombona A
Int J Mol Sci. 2025; 26(1.
PMID: 39796036
PMC: 11720130.
DOI: 10.3390/ijms26010178.
Integrating Physical and Biochemical Cues for Muscle Engineering: Scaffolds and Graft Durability.
Yousefi F, Foster L, Selim O, Zhao C
Bioengineering (Basel). 2025; 11(12.
PMID: 39768063
PMC: 11673930.
DOI: 10.3390/bioengineering11121245.
Bakuchiol from and its efficacy on apoptosis and autophagy in HepG2 cells.
Lee Y, Jang S, Song H, Kwon J, Ko M, Hong W
Heliyon. 2024; 10(23):e40758.
PMID: 39717592
PMC: 11664279.
DOI: 10.1016/j.heliyon.2024.e40758.
Inhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cells.
Kim J, Brunetti B, Kumar A, Mangla A, Honda K, Yoshida A
Cell Death Dis. 2024; 15(12):902.
PMID: 39695080
PMC: 11655860.
DOI: 10.1038/s41419-024-07284-3.
Loss of protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.
Lamas-Paz A, Hionides-Gutierrez A, Guo F, Jorquera G, Moran-Blanco L, Benede-Ubieto R
JHEP Rep. 2024; 7(1):101230.
PMID: 39659733
PMC: 11629569.
DOI: 10.1016/j.jhepr.2024.101230.
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
Hanf D, Fasching P, Gass P, Beckmann M, Hack C, Heindl F
Breast Cancer Res Treat. 2024; 210(1):125-134.
PMID: 39586971
PMC: 11787164.
DOI: 10.1007/s10549-024-07545-x.
Mechanisms of endocrine resistance in hormone receptor-positive breast cancer.
Gao Y, Yu Y, Zhang M, Yu W, Kang L
Front Oncol. 2024; 14:1448687.
PMID: 39544302
PMC: 11560879.
DOI: 10.3389/fonc.2024.1448687.
A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones.
Sanchez-Lanzas R, Barclay J, Hardas A, Kalampalika F, Jimenez-Pompa A, Gallipoli P
Leukemia. 2024; 39(2):460-472.
PMID: 39537978
PMC: 11794143.
DOI: 10.1038/s41375-024-02464-8.
A Necessary Role for Cyclin D2 Induction During Colon Cancer Progression Mediated by L1.
Saha A, Gavert N, Brabletz T, Ben-Zeev A
Cells. 2024; 13(21.
PMID: 39513917
PMC: 11544798.
DOI: 10.3390/cells13211810.
Patient with hormone receptor‑positive Her2‑negative metastatic breast cancer with visceral crisis with good response to abemaciclib and letrozole: A case report and review of the literature.
Wang Y, Zou X, Mao Y, Lv M, Li W
Mol Clin Oncol. 2024; 21(6):92.
PMID: 39478692
PMC: 11523261.
DOI: 10.3892/mco.2024.2790.
Evidence of apoptosis as an early event leading to cyclophosphamide-induced primordial follicle depletion in a prepubertal mouse model.
Hao X, Palomares A, Anastacio A, Liu K, Rodriguez-Wallberg K
Front Endocrinol (Lausanne). 2024; 15:1322592.
PMID: 39469582
PMC: 11514600.
DOI: 10.3389/fendo.2024.1322592.
